Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eplerenone versus spironolactone in men with cirrhosis-related ascites
2011-001264-22Phase 2Active
- Sponsor
- Region Skåne
- Start
- Oct 2012
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in Ascites in cirrhosis and Cirrhosis comparing Eplerenone + furosemide with Spironolactone + furosemide (2 arms). Primary endpoint: Absence of clinically detectable ascites. Started Oct 2012; status: active.
02
Drugs
eplerenonespironolactonefurosemide
03
Conditions
Ascites in cirrhosisCirrhosis
Beyond the preview
Go deeper on 2011-001264-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-001264-22.